Uncovering more options in cancer immunotherapy: High throughput screening platform for small molecules

www.sciencedaily.com

If scientists want to boost immune cells' ability to kill cancer cells, then vast libraries of small molecules are potentially available. A new paper shows a platform to sort through them, plus validation. One of the hits: IAP antagonist birinapant, which is already in clinical trials (coincidentally).

  • 0 Likes

  • 0 Comments